These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34112128)

  • 1. Vaccination coverage estimates and utilization patterns of inactivated enterovirus 71 vaccine post vaccine introduction in Ningbo, China.
    Ye L; Chen J; Fang T; Ma R; Wang J; Pan X; Dong H; Xu G
    BMC Public Health; 2021 Jun; 21(1):1118. PubMed ID: 34112128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the coverage of inactivated enterovirus 71 (EV71) vaccine and adverse events following immunization with the EV71 vaccine among children from 2016 to 2019 in Guangzhou.
    Li ZQ; Qin ZQ; Tan HF; Zhang CH; Xu JX; Chen J; Ni LH; Yun XX; Cui M; Huang Y; Wang W; Zhang ZB
    Expert Rev Vaccines; 2021 Jul; 20(7):907-918. PubMed ID: 34036862
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analysis of the vaccination status of enterovirus type 71 inactivated vaccine in China from 2017 to 2021].
    Zhang L; Cao L; Li Y; Hu YX; Tang L; Li KL; Yin ZD; An ZJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Apr; 44(4):561-567. PubMed ID: 37147826
    [No Abstract]   [Full Text] [Related]  

  • 4. Willingness and influential factors of parents to vaccinate their children with novel inactivated enterovirus 71 vaccines in Guangzhou, China.
    Li T; Wang H; Lu Y; Li Q; Chen C; Wang D; Li M; Li Y; Lu J; Chen Z; Ma Y; Liu W; Ma M; Wu D; Lu J; Yang Z
    Vaccine; 2018 Jun; 36(26):3772-3778. PubMed ID: 29776754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Willingness of parents to vaccinate their 6-60-month-old children with EV71 vaccines: a cross-sectional study in rural areas of northern Jiangsu Province.
    Wang Y; Meng F; Li J; Li G; Hu J; Cao J; Yu Q; Liang Q; Zhu F
    Hum Vaccin Immunother; 2020 Jul; 16(7):1579-1585. PubMed ID: 32209003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research progress on immune efficacy, safety, vaccination intention and immunization strategy of domestic enterovirus 71 vaccine after its marketing].
    Xu WJ; Chen EF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Sep; 54(9):1010-1016. PubMed ID: 32907294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine Pediatric Enterovirus 71 Vaccination in China: a Cost-Effectiveness Analysis.
    Wu JT; Jit M; Zheng Y; Leung K; Xing W; Yang J; Liao Q; Cowling BJ; Yang B; Lau EH; Takahashi S; Farrar JJ; Grenfell BT; Leung GM; Yu H
    PLoS Med; 2016 Mar; 13(3):e1001975. PubMed ID: 26978565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.
    Mao Q; Wang Y; Shao J; Ying Z; Gao F; Yao X; Li C; Ye Q; Xu M; Li R; Zhu F; Liang Z
    Hum Vaccin Immunother; 2015; 11(11):2723-33. PubMed ID: 25715318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enterovirus 71 vaccine acceptance among parents of children < 5 years old and their knowledge of hand, foot and mouth disease, Chongqing, China, 2017.
    Qi L; Su K; Xia Y; Tang W; Shen T; Li Q
    PLoS One; 2019; 14(11):e0225569. PubMed ID: 31774839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association between enterovirus 71 (EV71) vaccination and risk of febrile seizures: a population-based near real-time surveillance study.
    Sun Y; Zhang L; Li N; Zhao H; Ma R; Fang T; Yang T; Xu G; Liu Z; Zhan S
    Expert Rev Vaccines; 2022 Jan; 21(1):125-134. PubMed ID: 34860622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interchangeability of two Enterovirus 71 inactivated vaccines in Chinese children: A phase IV, open-label, and randomized controlled trial.
    Xu Q; Cao Q; Yang W; Liu X; Liu H; Tian X; Li J; Fang X; Jia N; Zeng G; Xu A
    Vaccine; 2020 Mar; 38(12):2671-2677. PubMed ID: 32067817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations for developing an immunization strategy with enterovirus 71 vaccine.
    Li L; Yin H; An Z; Feng Z
    Vaccine; 2015 Feb; 33(9):1107-12. PubMed ID: 25444807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An inactivated enterovirus 71 vaccine in healthy children.
    Li R; Liu L; Mo Z; Wang X; Xia J; Liang Z; Zhang Y; Li Y; Mao Q; Wang J; Jiang L; Dong C; Che Y; Huang T; Jiang Z; Xie Z; Wang L; Liao Y; Liang Y; Nong Y; Liu J; Zhao H; Na R; Guo L; Pu J; Yang E; Sun L; Cui P; Shi H; Wang J; Li Q
    N Engl J Med; 2014 Feb; 370(9):829-37. PubMed ID: 24571755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical safety assessment of a combined vaccine against Hepatitis a virus and enterovirus 71.
    Yang T; Liu B; Yue L; Xie T; Li H; Shao M; Yang R; Luo F; Long R; Xie Z
    Vaccine; 2021 Jun; 39(29):3952-3963. PubMed ID: 34088510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China.
    Zhu F; Xu W; Xia J; Liang Z; Liu Y; Zhang X; Tan X; Wang L; Mao Q; Wu J; Hu Y; Ji T; Song L; Liang Q; Zhang B; Gao Q; Li J; Wang S; Hu Y; Gu S; Zhang J; Yao G; Gu J; Wang X; Zhou Y; Chen C; Zhang M; Cao M; Wang J; Wang H; Wang N
    N Engl J Med; 2014 Feb; 370(9):818-28. PubMed ID: 24571754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of a national enterovirus 71 vaccination program in China.
    Wang W; Song J; Wang J; Li Y; Deng H; Li M; Gao N; Zhai S; Dang S; Zhang X; Jia X
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005899. PubMed ID: 28892475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: a report of further observations.
    Liu L; Mo Z; Liang Z; Zhang Y; Li R; Ong KC; Wong KT; Yang E; Che Y; Wang J; Dong C; Feng M; Pu J; Wang L; Liao Y; Jiang L; Tan SH; David P; Huang T; Zhou Z; Wang X; Xia J; Guo L; Wang L; Xie Z; Cui W; Mao Q; Liang Y; Zhao H; Na R; Cui P; Shi H; Wang J; Li Q
    BMC Med; 2015 Sep; 13():226. PubMed ID: 26381232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of an inactivated enterovirus 71 vaccine administered concurrently with other vaccines among infants aged 6-11 months: An observational study using active surveillance.
    Wu L; Zhang Y; Liu J; Huang Z; Shao H; Ma X; Sun X
    Hum Vaccin Immunother; 2024 Dec; 20(1):2412388. PubMed ID: 39402977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of enterovirus A71 vaccine in severe hand, foot, and mouth disease cases in Guangxi, China.
    Jiang L; Wang J; Zhang C; He W; Mo J; Zeng J; Chen M; Tan Y; Ning C
    Vaccine; 2020 Feb; 38(7):1804-1809. PubMed ID: 31892446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of protection for inactivated enterovirus 71 vaccine: the analysis of immunological surrogate endpoints.
    Zhu W; Jin P; Li JX; Zhu FC; Liu P
    Expert Rev Vaccines; 2017 Sep; 16(9):945-949. PubMed ID: 28548626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.